Cas:6180-99-0 tri-n-butyltin deuteride manufacturer & supplier

Chemical Name:tri-n-butyltin deuteride

CAS.NO:6180-99-0

Synonyms:Tributyltin deuteride;Tributylhydro-d-tin;Tributyldeuteriostannane;Tributyl-stannane-d;MFCD00064886;Tributylstannyl Deuteride;EINECS 211-704-4;tri-n-butyldeuteriostannane;Tri-n-butyltin deuteride

Molecular Formula:C₁₂H₂₇DSn

Molecular Weight:292.05800

HS Code:28459000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:65ºC (0.6 mmHg)

Density:1.082 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.472(lit.)

PSA:

Exact Mass:293.12800

LogP:4.61380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1993 3/PG 3

Packing Group:II

Contact us for information like Tributyltin deuteride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tri-n-butyltin deuteride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00064886 Use and application,EINECS 211-704-4 technical grade,usp/ep/jp grade.

Related News: In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. tri-n-butyltin deuteride manufacturer According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. tri-n-butyltin deuteride supplier In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. tri-n-butyltin deuteride vendor The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. tri-n-butyltin deuteride factory In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday.